We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Treatt Plc | LSE:TET | London | Ordinary Share | GB00BKS7YK08 | ORD 2P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
473.00 | 475.00 | 475.00 | 460.00 | 460.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 147.4M | 10.94M | 0.1802 | 26.36 | 286.92M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
11:18:00 | O | 437 | 472.784 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
04/12/2024 | 13:47 | UK RNS | Treatt PLC 2024 Final Dividend |
04/12/2024 | 13:40 | ALNC | EARNINGS: Treatt profit climbs; Oxford Metrics earnings fall |
04/12/2024 | 07:00 | UK RNS | Treatt PLC Full Year Results |
02/12/2024 | 07:00 | UK RNS | Treatt PLC Block Listing Six Monthly Return |
02/12/2024 | 07:00 | UK RNS | Treatt PLC Block Listing Six Monthly Return |
15/11/2024 | 07:00 | UK RNS | Treatt PLC Board Change |
16/10/2024 | 11:00 | UK RNS | Treatt PLC Change in Director's Duties |
10/10/2024 | 13:38 | ALNC | Treatt expects growth in annual profit following second-half momentum |
10/10/2024 | 06:00 | UK RNS | Treatt PLC Trading Update |
24/9/2024 | 13:06 | UK RNS | Treatt PLC Director/PDMR Shareholding |
Treatt (TET) Share Charts1 Year Treatt Chart |
|
1 Month Treatt Chart |
Intraday Treatt Chart |
Date | Time | Title | Posts |
---|---|---|---|
12/12/2024 | 08:00 | Treatt Thread With Charts | 1,167 |
16/8/2022 | 14:38 | Treatt -- interim financial results: anyone seen them? | 17 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
11:18:00 | 472.78 | 437 | 2,066.07 | O |
10:46:16 | 472.15 | 171 | 807.38 | O |
10:24:56 | 473.87 | 210 | 995.12 | O |
09:45:26 | 472.71 | 1,645 | 7,776.08 | O |
09:35:07 | 473.47 | 669 | 3,167.51 | O |
Top Posts |
---|
Posted at 12/12/2024 08:20 by Treatt Daily Update Treatt Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker TET. The last closing price for Treatt was 472.50p.Treatt currently has 60,723,167 shares in issue. The market capitalisation of Treatt is £288,435,043. Treatt has a price to earnings ratio (PE ratio) of 26.36. This morning TET shares opened at 460p |
Posted at 11/12/2024 10:13 by essentialinvestor Simon, we remain (for now) in the same trading range, approx £4-£5.TET has bounced from under £4, and the lower £4's multiple times now. I mentioned this the week before results. |
Posted at 11/12/2024 09:53 by simon gordon Citywire - 11/12/24:Treatt targets look tough, says Deutsche Deutsche Bank is expecting ingredients group Treatt (TET) to fall short of its premium ambitions over the coming years. Analyst Deirdre Mullaney retained her ‘hold’ recommendation and target price of 500p on the stock, which gained 3.2% to 490p yesterday. ‘We think management’s ambition to deliver two-thirds of revenue from its premium segment, from 25%, as likely to fall beyond our forecast period,’ Mullaney said. ‘We estimate that it could achieve 40% of sales from premium if the segment delivered 20% within five years, but that would be over twice as fast as our current forecasts for 9% growth.’ She said that she had ‘some reservations around underlying growth momentum into next year’ but expected ‘better visibility’ at the annual general meeting update in January. ‘Our unchanged price target of 500p indicates 8% potential total return upside,’ she explained. |
Posted at 05/12/2024 12:50 by simon gordon Citywire - 5/12/24:‘Buy’ Treatt, says Peel Hunt Ingredients and flavourings group Treatt (TET) is trading at a significant discount to peers but Peel Hunt believes it will soon start to narrow. Analyst Charles Hall reiterated his ‘buy’ recommendation and target price of 800p on the stock, which gained 6.1% to 456p on Wednesday. Full-year results from the group came in as expected with sales of £153m, £2m below the previously announced £155m as a hurricane delayed a shipment. Profit before tax was as expected at £19.1m. ‘The valuation gap to peers is still significant, and we expect it to narrow materially as confidence in the outlook improves,’ said Hall. ‘Treatt has more than 50% spare capacity and numerous growth opportunities ahead.’ Hall added that the company was ‘very well invested’ and has ‘strategic value’. |
Posted at 04/12/2024 08:08 by rimau1 Been on my watchlist and nibbled a starter position at 412, lazy question do TET expect a tarrif impact from Trump or do we have local manufacturing in the US |
Posted at 29/11/2024 00:04 by loofyloofy EI - Florida ´s crop is a complete irrelevance these days, the orange crop having fallen from more than 250M boxes 20-25 years ago to today ´s current 15M boxes. The fact that TET have US production is v positive, as the company could in theory set up two profit centres to help obviate a negative ´ginger nut´ trade policy . Of much more relevance is a recovery in the Braz orange crop, which has had 3 years of decline, unprecedented. Citrus as a category (now called heritage) is app. 50% of the TET business, so it would be wise for the new CEO to get his head around this category sooner rather than later. |
Posted at 28/11/2024 20:51 by 74tom I agree it does provide some context, but I don't think it explains why shares are on a 10% EV/FCF yield...On the 30/11/21 when TET released their FY21 full year results, shares traded at £11.50. They reported Adjusted EBITDA of £23.1m in FY21 vs this years trading update figure of £24.7m, so they have exceeded the FY21 high, albeit not by much. Should shares really be trading at 34% of that valuation?! Part of the reason could be due to the fall in return on capital employed, which has been caused by the addition of significant fixed assets (the CAPEX spend on the new premises / factory). At H121 Capital Employed was ~£100m & last 12 months operating profit was £19.5m, so a 19.5% ROCE. At H222, with the addition of net debt & fixed assets, Capital Employed had grown to £155m and ROCE had halved to 10.1%. Since then it has steadily improved, and as net debt is eliminated this will continue. I estimate Wednesday will show ROCE of ~14.5%, so whilst not back to 2021 levels, it justifies a share price well above where it currently sits (in my opinion). |
Posted at 28/11/2024 16:10 by simon gordon TET becomes particularly compelling when considering three key factors: the robust capacity platform established by the former CEO, the recent hyper-professionalis |
Posted at 28/11/2024 13:43 by 74tom I did some analysis of the fundamentals since 2017 and couldn't believe how cheap shares are right now.In the 7 year period from H117 to H223, TET traded on an average Price to Tangible Book of 4.15x, with a peak of ~6x in 2021 and a trough of 2.6x in H219. At the current share price it's valued at less than 1.75x This business is valued at £245m with just shy of £40m in land / building assets, zero net debt & which will have generated ~£60m in cashflow from operations over the last 3 years. It doesn't have lease liabilities either due to owning the freehold. If we consider the land / freehold to be cash, then it's trading on an EV/FCF yield of just under 10%. It also grew top line by 16% in H2 on a purely organic basis... At what point does a US fund just step in and relieve the idiot II's holding this? |
Posted at 20/11/2024 00:01 by essentialinvestor We are in an approximate £4-£5 range atm,with brief times spent both below and above those prices. I added another few back today, however the Trump dimension arguably makes TET higher risk - a larger competitor could always pounce, although that's highly speculative musing on my part. |
Posted at 01/11/2024 15:27 by essentialinvestor Perhaps the recent share price volatility is off putting, it can move lower rapidly for what appears little reason. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions